prikaz prve stranice dokumenta An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
Rad je dostupan svim korisnicima iz sustava znanosti i visokog obrazovanja RH
Znanstveni rad - Pregledni rad
An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
The Lancet Global Health, 11 (2023), 3; e466-e474. https://doi.org/10.1016/S2214-109X(23)00019-0
Charani, Esmita; Mendelson, Marc; Pallett, Scott J C; Ahmad, Raheelah; Mpundu, Mirfin; Mbamalu, Oluchi; Bonaconsa, Candice; Nampoothiri, Vrinda; Singh, Sanjeev; Peiffer-Smadja, Nathan; Anton-Vazquez, Vanesa; Moore, Luke S P; Schouten, Jeroen; Kostyanev, Tomislav; Vlahović-Palčevski, Vera; Kofteridis, Diamantis; Corrêa, Juliana Silva; Holmes, Alison H Više autora...

Citirajte ovaj rad

Charani, E., Mendelson, M., Pallett, S. J. C., Ahmad, R., Mpundu, M., Mbamalu, O. ... Holmes, A. H. (2023). An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations. The Lancet Global Health, 11. (3), e466-e474. doi: 10.1016/S2214-109X(23)00019-0

Charani, Esmita, et al. "An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations." The Lancet Global Health, vol. 11, br. 3, 2023, str. e466-e474. https://doi.org/10.1016/S2214-109X(23)00019-0

Charani, Esmita, Marc Mendelson, Scott J C Pallett, Raheelah Ahmad, Mirfin Mpundu, Oluchi Mbamalu, Candice Bonaconsa, et al. "An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations." The Lancet Global Health 11, br. 3 (2023): e466-e474. https://doi.org/10.1016/S2214-109X(23)00019-0

Charani, E., et al. (2023) 'An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations', The Lancet Global Health, 11(3), str. e466-e474. doi: 10.1016/S2214-109X(23)00019-0

Charani E, Mendelson M, Pallett SJC, Ahmad R, Mpundu M, Mbamalu O, i sur.. An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations. The Lancet Global Health [Internet]. 02.02.2023. [pristupljeno 27.10.2024.];11(3):e466-e474. doi: 10.1016/S2214-109X(23)00019-0

E. Charani, et al., "An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations", The Lancet Global Health, vol. 11, br. 3, str. e466-e474, Veljača 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:684710. [Citirano: 27.10.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:684710
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)An analysis of existing national action plans for antimicrobial resistance—gaps and opportunities in strategies optimising antibiotic use in human populations
AutorEsmita Charani
AutorMarc Mendelson
AutorScott J C Pallett
AutorRaheelah Ahmad
AutorMirfin Mpundu
AutorOluchi Mbamalu
AutorCandice Bonaconsa
AutorVrinda Nampoothiri
AutorSanjeev Singh
AutorNathan Peiffer-Smadja
AutorVanesa Anton-Vazquez
AutorLuke S P Moore
AutorJeroen Schouten
AutorTomislav Kostyanev
AutorVera Vlahović-Palčevski
AutorDiamantis Kofteridis
AutorJuliana Silva Corrêa
AutorAlison H Holmes
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za farmakologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Farmakologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Javno zdravstvo i zdravstvena zaštita
Sažetak (engleski)
At the 2015 World Health Assembly, UN member states adopted a resolution that committed to the development of national action plans (NAPs) for antimicrobial resistance (AMR). The political determination to commit to NAPs and the availability of robust governance structures to assure sustainable translation of the identified NAP objectives from policy to practice remain major barriers to progress. Inter-country variability in economic and political resilience and resource constraints could be fundamental barriers to progressing AMR NAPs. Although there have been regional and global analyses of NAPs from a One Health and policy perspective, a global assessment of the NAP objectives targeting antimicrobial use in human populations is needed. In this Health Policy, we report a systematic evidence synthesis of existing NAPs that are aimed at tackling AMR in human populations. We find marked gaps and variability in maturity of NAP development and operationalisation across the domains of: (1) policy and strategic planning; (2) medicines management and prescribing systems; (3) technology for optimised antimicrobial prescribing; (4) context, culture, and behaviours; (5) operational delivery and monitoring; and (6) patient and public engagement and involvement. The gaps identified in these domains highlight opportunities to facilitate sustainable delivery and operationalisation of NAPs. The findings from this analysis can be used at country, regional, and global levels to identify AMR-related priorities that are relevant to infrastructure needs and contexts.
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaThe Lancet Global Health
Brojčani podacivol. 11, br. 3, str. e466-e474
p-ISSN2214-109X
DOIhttps://doi.org/10.1016/S2214-109X(23)00019-0
URN:NBNurn:nbn:hr:184:684710
Datum objave elektroničkog izdanja2023-02-02
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S2214109X23000190
Vrsta resursaTekst
Prava pristupaOgraničen pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2023-05-17 08:44:31